SignalGene Inc.

SignalGene's mission is to create value for its stakeholders through the application of genomics to the development of improved prognostics and therapeutics for human diseases. SignalGene's business strategy is based on the following elements: Consolidate assets in Genomics Research: SignalGene is assembling genomics enabling technologies and research programs through a combination of collaborations, partnerships and acquisitions. The Company's goal is to construct an integrated platform for gene discovery and target validation. - Generate revenues through Strategic Alliances and Genetic Testing Services: SignalGene is pursuing short-term revenue generation through Strategic Alliances based on its genomics research programs. The Company has also launched a commercial Genetic Testing service targeting the emerging Pharmacogenomics and Genetic Prognostics markets. - Capture value through Drug Discovery and Development: SignalGene intends to exploit proprietary targets for the discovery and development of small molecule drugs as therapeutics.

Activity:

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: